Thursday, April, 18, 2019 09:16:13

Viking Therapeutics to present data from Phase 2 study of VK2809

Clinical-stage biopharmaceutical company Viking Therapeutics, Inc. will reportedly present data from its 12-week long Phase 2 trial of VK2809 on individuals suffering from non-alcoholic fatty liver disease and elevated low-density lipoprotein cholesterol at the International Liver Congress™ 2019. According to familiar sources, the study results …

Cellgen, GTC unite to develop companion tests for cancer therapies

The two firms will focus on accelerating global development of companion tests for several oncology therapies. Renowned precision diagnostics firm, Cellgen Diagnostics has recently announced a strategic collaboration with Genomic Testing Cooperative (GTC) to help accelerate global development of companion tests for various oncology therapeutics. …

Sangamo & Pfizer unveil data from gene therapy for severe hemophilia A

More than eight individuals treated with the SB-525 gene therapy demonstrated increases in FVIII activity that was dose-dependent. The FVIII levels reached normal in two patients that were treated with a 3e13 vg/kg dose. Sangamo Therapeutics, Inc., (Sangamo), a California-based biotechnology company, and New York-based …

Medical wearable start-up Ten3T raises funding from ITI Growth Fund

ten3T will reportedly use the funds to expand the usability of their product called Cicer for ambulance monitoring, pharmacovigilance studies and homes. ten3T Healthcare Pvt. Ltd, a Bengaluru based medical wearable device startup, has reportedly raised an unrevealed amount in a pre-Series A funding round. …

Neon Therapeutics unveils new data in clinical trial of cancer vaccine

The study will evaluate the combination of NEO-PV-01 with nivolumab (anti-PD-1 therapy) in metastatic or advanced melanoma patients Neon Therapeutics Inc., an immuno-oncology company which develops neoantigen-based treatments has reportedly presented updated data that describes pathologic and immune markers related with durable clinical advantages in …